CCND1 and lymphoma: By tracking the lymphoma with luciferase signaling in vivo for A20 or cell counts for BCL1, we found that allogeneic BMT mediated the clearance of inoculated A20 and BCL1 cells in both anti-RGMb or isotype control treated mice (Figures 3C, E).